#IDIBELLfellows: Virginia Díez-Obrero / Léa Pourchet

Virginia Díez-Obrero
Léa Pourchet

Colorectal Cancer Group
Stem Cell Potency Group

09/03/2021 15:00-16:00

Microsoft Teams


#IDIBELLconnect: Dissecting mechanisms of therapy resistance in lethal prostate cancer

Alvaro Aytés

Resistance and Progression Mechanisms in Prostate Cancer Group, IDIBELL

26/02/2021 13:00-14:00

Microsoft Teams


#IDIBELLfellows: Carmen Martínez-Fernández / Mercè Cases Escuté

Carmen Martínez-Fernández
Mercè Cases Escuté

Modeling Human Diseases in C. elegans Group
Cellular and Molecular Neurobiology Group

23/02/2021 15:00-16:00

Microsoft Teams


Joint webinar #IDIBELLseminars #IDIBELLequality: Social and mental health impact on women in times of COVID-19

Zulema Altamirano
Susana Jiménez

Senior Officer at the Cabinet of the Minister of Science & Innovation – Director of the Women & Science Unit, Spain
Psychiatry and Mental Health research group, and head of the Pathological Gambling Unit, HUB

12/02/2021 13:00-14:00

Microsoft teams


#IDIBELLconnect: Modeling cellular plasticity to regenerate the intestine

Jordi Guiu

Bellvitge Biomedical Research Institute (IDIBELL), Spain
Program for Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C])

29/01/2021 13:00-14:00

Microsoft Teams Meeting


Webinar IRISCAT-Dr. Rafael Máñez «Generació d’immunitat protectora contra les infeccions»

Rafael Máñez Mendiluce

Cap del Servei de Medicina Intensiva. Hospital Universitari de Bellvitge.

20/01/2021 16:00-

Online


#IDIBELLconnect: The TGF-β pathway: A pharmacological target in hepatocellular carcinoma?

Isabel Fabregat

Bellvitge Biomedical Research Institute (IDIBELL), Spain
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd), Spain
University of Barcelona (UB), Spain

15/01/2021 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


Charlas Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online y en directo:
https://sinergia.l-h.cat/



#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
Founder and President of the IDIBELL spin-off RemAb Therapeutics

20/11/2020 13:00-14:00

Microsoft Teams Meeting


PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

Microsoft Teams meeting



Ir arriba